Peter Liu赞助的临床试验
总计1320个结果
-
University of AarhusAarhus University Hospital; The Alfred; The Peter Doherty Institute for Infection and Immunity; Walter...招聘中
-
Murdoch Childrens Research InstituteMonash University; St Vincent's Hospital Melbourne; University of Melbourne; The Peter Doherty Institute... 和其他合作者招聘中
-
University of SydneyAustin Health; Peter MacCallum Cancer Centre, Australia; Western Sydney Local Health District; Princess... 和其他合作者招聘中
-
LMU KlinikumMedtronic Bakken Research Center; Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)完全的
-
SBÜ Dr. Sadi Konuk Eğitim ve Araştırma HastanesiIstinye University; Liv Hospital (Ulus)完全的
-
Lei Li招聘中
-
Li Zhang, MD尚未招聘非小细胞癌 | 表皮生长因子受体基因突变中国
-
National Taiwan University HospitalYu-Li Hospital完全的
-
Centre for Addiction and Mental HealthBreaking Free Online (BFO); Community Addictions Peer Support Association (CAPSA)招聘中
-
Lei Li招聘中复发性宫颈癌 | 放疗 | 免疫检查点抑制剂 | 总生存期 | 抗程序性死亡-1 抗体 | 转移性宫颈癌 | 持续性晚期宫颈癌 | 客观缓解率 | 无进展生存期 | 严重不良事件中国
-
Li Zhang, MD招聘中诊断为 ALK 阳性 NSCLC | 第二代 ALK-TKI 耐药 | Ensatinib 在这部分患者中的疗效中国
-
Lei Li招聘中
-
Chinese PLA General HospitalLu jiang hospital完全的